Cellebrite
CLBT
49 hedge funds and large institutions have $247M invested in Cellebrite in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 12 closing their positions.
267% more call options, than puts
Call options by funds: $411K | Put options by funds: $112K
73% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 11
2% more funds holding
Funds holding: 48 → 49 (+1)
1.07% more ownership
Funds ownership: 19.56% → 20.63% (+1.1%)
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
16% less capital invested
Capital invested by funds: $294M → $247M (-$46.4M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$11.5M |
| 2 |
GRIM
Greenhaven Road Investment Management
Greenwich,
Connecticut
|
+$5.45M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$4.17M |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$3.36M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Telemark Asset Management
Boston,
Massachusetts
|
-$8.02M |
| 2 |
BCM
Bienville Capital Management
New York
|
-$7.67M |
| 3 |
GIP
General Industrial Partners
London,
United Kingdom
|
-$4.28M |
| 4 |
CPM
Crescent Park Management
East Palo Alto,
California
|
-$2.67M |
| 5 |
IP
Isomer Partners
New York
|
-$1.43M |
CLBT Hedge Fund Activity: Q1 2022 in Review
49 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q1 2022, worth a combined $247M — down 16% from $294M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CLBT positions and 12 closed out — a net gain of 1 holder — while 19 added to existing stakes and 11 trimmed.
The largest buyer was Phoenix Financial, adding an estimated $11.5M. The largest seller was Telemark Asset Management, exiting entirely with an estimated $8.02M sold.
- 49 institutional investors held Cellebrite (CLBT) as of Q1 2022, up from 48 in Q4 2021.
- Funds reported $247M of Cellebrite stock for Q1 2022, down 16% quarter-over-quarter.
- 13 funds opened new Cellebrite positions in Q1 2022 and 12 closed out, a net change of +1 holder.
- The largest Cellebrite buyer in Q1 2022 was Phoenix Financial, an estimated $11.5M added.
- The largest Cellebrite seller in Q1 2022 was Telemark Asset Management, an estimated $8.02M sold.
Based on aggregated 13F filings for Q1 2022.